ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a


SEARCH JOBS


Industry
Services






 Company News
PharmaEngine, Inc. Announces Filing By Baxter BioScience Corporation (BAX) Of Marketing Authorization Application Of MM-398 (PEP02) To The European Medicines Agency For Post-Gemcitabine Metastatic Pancreatic Cancer Patients 5/4/2015 9:02:45 AM
European Medicines Agency Grants Orphan Designation For Makindus' MI-100 For Stargardt's Disease 5/4/2015 8:55:49 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Pancreatic Cancer 4/29/2015 6:33:34 AM
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency 4/27/2015 8:29:29 AM
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency 4/20/2015 8:04:34 AM
European Medicines Agency's PRAC Recommends Updating Advice On Use Of High Dose Ibuprofen 4/13/2015 9:50:02 AM
Mesoblast Limited (MSB.AX) Phase 3 Program For Degenerative Disc Disease To Include European Sites After Positive Meeting With European Medicines Agency 4/8/2015 7:14:13 AM
Repros Therapeutics Inc. (RPRX) Receives Confirmation Of Eligibility For Submission Of A Centralized Marketing Authorization Application To The European Medicines Agency As A New Active Substance 4/7/2015 7:10:26 AM
European Medicines Agency Release: Making A Difference To Human And Animal Health 3/31/2015 8:46:07 AM
European Medicines Agency Commences Review Of CSL Behring's Regulatory Submission For Rix-FP For Hemophilia B Patients 3/30/2015 12:50:45 PM
12345678910...